Pilot study of Conformal Intensity Modulated Radiation Therapy for Localized Prostate Cancer;Étude de faisabilité de radiothérapie de conformation avec modulation d'intensité dans les cancers localisés de la prostate

Cancer/Radiotherapie

Volumn 8, Issue 2, 2004, Pages 59-69

  Ailleres N ^a   Azria, D ^a   Thezenas S ^a   Barbier, N ^a   Fenoglietto, P ^a   Delard, R ^a   Hay, M H ^a   Dubois, J B ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

Cancer de la prostate; Intensity modulation; Modulation d'intensit ; Prostate cancer; Radioth rapie; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLLIMATOR; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; GAMMA RADIATION; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL ASSESSMENT; PATIENT SELECTION; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTECTION; RADIATION DOSE; RADIATION RESPONSE; RECTUM; STATISTICAL ANALYSIS; TECHNIQUE; TOXICITY; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGED; DIGESTIVE SYSTEM; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; UROGENITAL SYSTEM;

EID: 19244385422     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2003.10.007     Document Type: Article

References (43)

1. Bastasch M.D., Teh B.S., Mai W.Y., Carpenter L.S., Lu H.H., Chiu J.K., et al. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys. 54:2002;101-106.
2. Beckendorf V., Guerif S., Le Prise E., Bey P., Cosset J., Le Floch O., et al. The French 70 Gy vs 80 Gy dose escalation trial for localized prostate cancer: feasibility and toxicity. Int J Radiat Oncol Biol Phys. 57:2003;152-153. (2003).
3. Bey P., Beckendorf V., Aletti P., Marchesi V. Conformal radiotherapy in prostate cancer: for whom and how? Cancer Radiother. 6:2002;147-153.
4. Bey P., Beckendorf V., Stines J. Prostate cancer. Cancer Radiother. 5:2001;560-570.
5. Bolla M., Collette L., Blank L., Warde P., Dubois J.B., Mirimanoff R.O., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 360:2002;103-106.
6. Bolla M., Gonzalez D., Warde P., Dubois J.B., Mirimanoff R.O., Storme G., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.
7. Dearnaley D., Hall E., Jackson C., Lawrence D., Huddart R., Eeles R., et al. Phase III Trial of Conformal Radiotherapy Following Neoadjuvant Hormone Treatment in Early Prostate Cancer [abstract]. Proc ASTRO. 54:2002;228.
8. Dearnaley D.P., Khoo V.S., Norman A.R., Meyer L., Nahum A., Tait D., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 353:1999;267-272.
9. Eisbruch A., Marsh L.H., Martel M.K., Ship J.A., Ten Haken R., Pu A.T., et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys. 41:1998;559-568.
10. Fisch B.M., Pickett B., Weinberg V., Roach M. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology. 57:2001;955-959.
11. Hanks G.E., Martz K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
12. Khoo V.S., Oldham M., Adams E.J., Bedford J.L., Webb S., Brada M. Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys. 45:1999;415-425.
13. Knoos T., Kristensen I., Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys. 42:1998;1169-1176.
14. Koper P.C., Stroom J.C., van Putten W.L., Korevaar G.A., Heijmen B.J., Wijnmaalen A., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys. 43:1999;727-734.
15. Langen K.M., Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys. 50:2001;265-278.
16. Lawton C.A., Won M., Pilepich M.V., Asbell S.O., Shipley W.U., Hanks G.E., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:1991;935-939.
17. LoSasso T., Chui C.S., Ling C.C. Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys. 25:1998;1919-1927.
18. Malone S., Crook J.M., Kendal W.S., Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys. 48:2000;105-109.
19. Nutting C.M., Convery D.J., Cosgrove V.P., Rowbottom C., Padhani A.R., Webb S., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;649-656.
20. Peschel R.E., Colberg J.W. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol. 4:2003;233-241.
21. Pollack A., Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:1997;1011-1018.
22. Pollack A., Zagars G.K., Smith L.G., Lee J.J., von Eschenbach A.C., Antolak J.A., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
23. Purdy J.A. Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 35:1996;845-846.
24. Roach M. 3rd, Lu J., Pilepich M.V., Asbell S.O., Mohiuddin M., Terry R., et al. Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys. 47:2000;617-627.
25. Roach M. 3rd, Pickett B., Weil M., Verhey L. The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;1019-1025.
26. Schellhammer P.F. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better? Int J Radiat Oncol Biol Phys. 41:1998;489-490.
27. Sethi A., Mohideen N., Leybovich L., Mulhall J. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys. 55:2003;970-978.
28. Smit W.G., Helle P.A., van Putten W.L., Wijnmaalen A.J., Seldenrath J.J., van der Werf-Messing B.H. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys. 18:1990;23-29.
29. Spirou S.V., Chui C.S. Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators. Med Phys. 21:1994;1031-1041.
30. Spirou S.V., Chui C.S. A gradient inverse planning algorithm with dose-volume constraints. Med Phys. 25:1998;321-333.
31. Storchi P., Woudstra E. Calculation of the absorbed dose distribution due to irregularly shaped photon beams using pencil beam kernels derived form basic beam data. Phys Med Biol. 41:1996;637-656.
32. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642.
33. Teh B.S., Woo S.Y., Butler E.B. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist. 4:1999;433-442.
34. Trotti A., Byhardt R., Stetz J., Gwede C., Corn B., Fu K., et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;13-47.
35. Trotti A., Colevas A.D., Setser A., Rusch V., Jaques D., Budach V., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 13:2003;176-181.
36. Van Esch A., Bohsung J., Sorvari P., Tenhunen M., Paiusco M., Iori M., et al. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments. Radiother Oncol. 65:2002;53-70.
37. Woo S.Y., Sanders M., Grant W., Butler E.B. Does the "peacock" have anything to do with radiotherapy? Int J Radiat Oncol Biol Phys. 29:1994;213-214.
38. Zelefsky M.J., Cowen D., Fuks Z., Shike M., Burman C., Jackson A., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468.
39. Zelefsky M.J., Fuks Z., Happersett L., Lee H.J., Ling C.C., Burman C.M., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 55:2000;241-249.
40. Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 166:2001;876-881.
41. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116.
42. Zelefsky M.J., Happersett L., Leibel S.A., Burman C.M., Schwartz L., Dicker A.P., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 37:1997;13-19.
43. Zelefsky M.J., Leibel S.A., Gaudin P.B., Kutcher G.J., Fleshner N.E., Venkatramen E.S., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.